Antibodies to Human Immunodeficiency Virus type Test
CAT # | PRODUCT | DESCRIPTION | SPECIMEN | CUT-OFF | SENSITIVITY | SPECIFICITY | ACCURACY | FORMAT | KIT SIZE |
RS120C |
HIV 1.2.O |
Antibodies to Human Immunodeficiency Virus type 1,2 and O Test;3-line |
WB/S/P |
N/A |
100.00% |
98.50% |
99.30% |
Cassette |
25T |
RS111S |
HIV 1/2 Ab |
Antibodies to Human Immunodeficiency Virus type 1 and type 2 Test |
Serum/Plasma |
N/A |
99.31% |
100.00% |
99.81% |
Strip |
*50T/100T |
RS111C |
HIV 1/2 Ab |
Antibodies to Human Immunodeficiency Virus type 1 and type 2 Test |
Serum/Plasma |
N/A |
99.31% |
100.00% |
99.81% |
Cassette |
25T |
RS112S |
HIV 1/2 Ab |
Antibodies to Human Immunodeficiency Virus type 1 and type 2 Test |
WB/S/P |
N/A |
99.50% |
99.80% |
99.80% |
Strip |
50T |
RS112C |
HIV 1/2 Ab |
Antibodies to Human Immunodeficiency Virus type 1 and type 2 Test |
WB/S/P |
N/A |
99.50% |
99.80% |
99.80% |
Cassette |
25T |
RS113C |
HIV 1/2 Ab-individual |
Antibodies to Human Immunodeficiency Virus type 1 and type 2 Test |
WB/S/P |
N/A |
99.50% |
99.80% |
99.80% |
Cassette |
25T |
RSHIVCB |
HIV 1/2 Ab Saliva |
I+CareTM Human Immunodeficiency Virus Antibodies Type 1 and 2 Saliva Test 1Test/Kit |
Saliva |
N/A |
98.28% |
99.87% |
99.20% |
Cassette |
1T |
RSHIVCⅡ |
HIV 1/2 Ab Saliva |
Human Immunodeficiency Virus Antibodies Type 1 and 2 Saliva Test |
Saliva |
N/A |
98.28% |
99.87% |
99.20% |
Cassette |
20T |
The Human Immunodeficiency Viruses type 1 and type 2 are etiological agents of the acquired immunodeficiency syndrome (AIDS). HIV has been isolated from patients with AIDS, AIDS related complex (ARC) and from healthy individuals at high risk for AIDS. Infection with HIV is followed by an acute flu-like illness. This phase may remain unnoticed and the relationship to HIV infection may not be clear in many cases. The acute phase is typically followed by an asymptomatic carrier state, which progresses to clinical AIDS in about 50% of infected individuals within 10 years after seroconversion. Serological evidence of HIV infection may be obtained by testing for HIV antigens or antibodies in serum of individuals suspected of HIV infection. Antigen can generally be detected during the acute phase and during the symptomatic phase of AIDS only. Antibodies to HIV-1 and/or HIV-2 can be detected throughout virtually the total infection period, starting at or shortly after the acute phase and lasting until the end stage of AIDS. Therefore, the use of highly sensitive antibody assays is the primary approach in serodiagnosis of HIV infection. The EUGENE® HIV1/2 Ab rapid test (whole blood/Serum/Plasma)utilizes colloidal gold conjugated multiple recombinant HIV proteins to selectively detect to the presence of antibodies to HIV 1 and HIV2 in whole blood, serum or plasma. It can be performed easily without extra laboratory equipment.